Anne Bang joined the Sanford Burnham Prebys in June 2010 as Director of Cell Biology at the Conrad Prebys Center for Chemical Genomics, a state-of-the-art drug discovery center. Her efforts there are directed at developing patient-specific, and human induced pluripotent stem cell (hiPSC)-based models that reflect higher order cellular functions and disease phenotypes, yet have the throughput and reproducibility required for drug discovery and target identification. Prior to joining SBP she was at ViaCyte Inc. where, as Director of Stem Cell Research, she managed an interdisciplinary group of scientists working to develop hESC as a replenishable source of pancreatic cells for the treatment of diabetes. Dr. Bang has over 20 years of experience in the fields of developmental and stem cell biology, with a focus on neural development. She received a B.S. from Stanford, a Ph.D. in Biology from UCSD, and was a post-doctoral fellow at the Salk Institute.